scholarly article | Q13442814 |
P2093 | author name string | Mitnick H | |
Burde RM | |||
Kupersmith MJ | |||
Warren FA | |||
Klingele TG | |||
Frohman LP | |||
P2860 | cites work | Multiple sclerosis presenting with progressive visual failure | Q33620218 |
Ocular findings in systemic lupus erythematosus. | Q33996228 | ||
Glucocorticosteroid therapy: mechanisms of action and clinical considerations | Q34058573 | ||
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. | Q34253953 | ||
Reopening filtration fistulas with the argon laser | Q36654276 | ||
Circulating immune complexes in multiple sclerosis and other neurological diseases | Q39405572 | ||
The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
Disease markers in acute multiple sclerosis | Q45038216 | ||
MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis | Q48257185 | ||
The ocular manifestations of the diffuse collagen diseases. | Q51060741 | ||
A collagen disorder of the nervous system presenting as multiple sclerosis. | Q51114814 | ||
Optic neuritis in systemic lupus erythematosus. | Q53703134 | ||
Malignancy following treatment of rheumatoid arthritis with cyclophosphamide | Q59647405 | ||
Devic's syndrome and systemic lupus erythematosus: a case report with necropsy | Q66938486 | ||
The neuro-ophthalmology of systemic lupus erythematosus | Q66980031 | ||
Evidence of local synthesis of smooth-muscle antibodies in the central nervous system in isolated cases of multiple sclerosis and chronic lymphocytic meningoencephalitis | Q67566314 | ||
A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature | Q67857833 | ||
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
Optic neuropathy in systemic lupus erythematosus | Q70025996 | ||
Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial | Q70037367 | ||
Antinuclear antibodies in multiple sclerosis | Q70251695 | ||
Primary idiopathic inflammation of the optic nerve | Q70327924 | ||
The neurological manifestations of systemic lupus erythematosus | Q70861096 | ||
Immunofluorescent studies of the kidney in human neurologic disorders | Q71755096 | ||
Circulating immune complexes in multiple sclerosis: relation with disease activity | Q72113006 | ||
Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis | Q72435168 | ||
Recurrent bilateral optic neuropathy in mixed connective tissue disease | Q72792489 | ||
Neurologic signs and symptoms as early manifestations of systemic lupus erythematosus | Q73733561 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Autoimmune optic neuropathy | Q17080979 |
P304 | page(s) | 1381-1386 | |
P577 | publication date | 1988-11-01 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Autoimmune optic neuropathy: evaluation and treatment | |
P478 | volume | 51 |
Q33571553 | Anterior ischemic optic neuropathy |
Q36575015 | Autoimmune optic neuropathy |
Q28196877 | Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a child |
Q37239284 | Clinical approach to optic neuropathies. |
Q35761837 | Clinical profile of simultaneous bilateral optic neuritis in adults |
Q36173222 | Current options for the treatment of optic neuritis |
Q77729932 | Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial |
Q24678418 | Demyelination in rheumatic diseases |
Q38766838 | Investigation-Directed Approach to Inflammatory Optic Neuropathies |
Q48616813 | Microangiopathy with retinopathy, encephalopathy, and deafness (RED-M) and systemic features |
Q74530411 | Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis |
Q37551707 | Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage |
Q43557553 | Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome |
Q81665245 | Progressive visual loss: an unusual presentation of multiple sclerosis |
Q42842231 | The approach to bilateral simultaneous isolated optic neuritis |
Q72357289 | The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial |
Q34680879 | The neuropathology and pathogenesis of systemic lupus erythematosus |
Q34005484 | The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis |
Q38275636 | Treatment options for atypical optic neuritis |
Q36587202 | Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis |
Q35592042 | Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease. |
Q81685681 | [Optic neuritis associated with infliximab] |